Efficacy of Levonorgestrel-Releasing Intrauterine System for Treatment of Atypical Endometrial Hyperplasia

Efficacy of Levonorgestrel-Releasing Intrauterine System for Treatment of Atypical Endometrial Hyperplasia - LNG-IUS for Treatment of Atypical Endometrial Hyperplasia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016528

Enrollment

Registered

2015-02-20

Start date

2015-02-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atypical endometrial hyperplasia, complex

Interventions

Levonorgestrel-releasing intrauterine device

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Age 20 and over 2. Patients must have signed an approved informed consent.

Exclusion criteria

Exclusion criteria: 1. No active luteal hormone dependent tumor 2. No advanced endometrial cancer

Design outcomes

Primary

Measure	Time frame
Pre- and post-treatment pathological findings of endometrial hyperplasia	—

Countries

Japan

Contacts

Public ContactTakashi Mitamura

Hokkaido University Hospital Department of Obstetrics and Gynecology

takami@huhp.hokudai.ac.jp011-706-5941

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026